Oliva-Damaso, NestorBomback, Andrew S2023-02-092023-02-092020-11-20http://hdl.handle.net/10668/16642enAntibodies, Monoclonal, HumanizedClinical Trials, Phase III as TopicDouble-Blind MethodHumansLupus NephritisMulticenter Studies as TopicRandomized Controlled Trials as TopicTreatment OutcomeBelimumab in Lupus Nephritis: New Trial Results Arrive During an Exciting Time for Therapeutics.research article33221369open access10.1053/j.ajkd.2020.11.0031523-6838http://www.ajkd.org/article/S0272638620311240/pdf